LISA BOUILLION: Open Payments
NPI 1437617719 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$735 in 39 payments from 15 companies in 2025. Trend: 2023 $1,785 · 2024 $1,365 · 2025 $735
Food & beverage: $735
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $158 |
| Lilly USA, LLC | 6 | $113 |
| PFIZER INC. | 3 | $76 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $53 |
| Amgen Inc. | 3 | $46 |
| GlaxoSmithKline, LLC. | 2 | $44 |
| ABBVIE INC. | 2 | $43 |
| Exact Sciences Corporation | 2 | $39 |
| HARMONY BIOSCIENCES LLC | 2 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $28 |
Products named: JARDIANCE, MOUNJARO, PREVNAR 20, OTEZLA, TRELEGY ELLIPTA, Cologuard Collection Kit, WAKIX, VRAYLAR.
Industry payments across TX — which companies pay providers there.
